Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ablation Techniques | 19 | 2023 | 248 | 6.680 |
Why?
|
Microwaves | 16 | 2022 | 185 | 6.310 |
Why?
|
Radiography, Interventional | 43 | 2021 | 1112 | 5.790 |
Why?
|
Catheter Ablation | 32 | 2022 | 2740 | 3.730 |
Why?
|
Carcinoma, Renal Cell | 24 | 2021 | 3217 | 3.590 |
Why?
|
Kidney Neoplasms | 29 | 2021 | 4312 | 3.480 |
Why?
|
Liver Neoplasms | 28 | 2022 | 4313 | 3.330 |
Why?
|
Tomography, X-Ray Computed | 62 | 2021 | 20500 | 2.600 |
Why?
|
Carcinoma, Hepatocellular | 11 | 2022 | 2292 | 1.960 |
Why?
|
Cryosurgery | 5 | 2020 | 475 | 1.780 |
Why?
|
Surgery, Computer-Assisted | 11 | 2023 | 1008 | 1.740 |
Why?
|
Embolization, Therapeutic | 8 | 2021 | 1407 | 1.690 |
Why?
|
Electroporation | 6 | 2023 | 254 | 1.690 |
Why?
|
Drainage | 17 | 2023 | 1161 | 1.500 |
Why?
|
Gastrostomy | 3 | 2024 | 321 | 1.190 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 2 | 2021 | 506 | 1.090 |
Why?
|
Yttrium Radioisotopes | 2 | 2018 | 107 | 1.070 |
Why?
|
Radiology, Interventional | 8 | 2021 | 475 | 1.060 |
Why?
|
Ultrasonography, Interventional | 10 | 2018 | 1489 | 0.980 |
Why?
|
Abdominal Abscess | 4 | 2017 | 152 | 0.950 |
Why?
|
Retroperitoneal Space | 3 | 2018 | 171 | 0.950 |
Why?
|
Lymph Nodes | 5 | 2018 | 3485 | 0.810 |
Why?
|
Biliary Tract Diseases | 2 | 2021 | 157 | 0.780 |
Why?
|
Enbucrilate | 1 | 2021 | 30 | 0.750 |
Why?
|
Pelvis | 6 | 2018 | 743 | 0.740 |
Why?
|
Aged, 80 and over | 49 | 2024 | 58683 | 0.730 |
Why?
|
Treatment Outcome | 48 | 2022 | 64378 | 0.720 |
Why?
|
Ureteral Diseases | 2 | 2018 | 65 | 0.710 |
Why?
|
Granuloma, Plasma Cell | 1 | 2021 | 80 | 0.700 |
Why?
|
Lymphatic Metastasis | 6 | 2018 | 2943 | 0.670 |
Why?
|
Retrospective Studies | 50 | 2024 | 80168 | 0.670 |
Why?
|
Mesentery | 2 | 2017 | 202 | 0.660 |
Why?
|
Sodium Chloride | 3 | 2017 | 588 | 0.660 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2021 | 194 | 0.630 |
Why?
|
Kidney Diseases | 2 | 2021 | 2083 | 0.600 |
Why?
|
Uveal Neoplasms | 2 | 2018 | 341 | 0.600 |
Why?
|
Aged | 75 | 2024 | 168218 | 0.590 |
Why?
|
Cholangiocarcinoma | 4 | 2019 | 550 | 0.580 |
Why?
|
Middle Aged | 78 | 2024 | 219568 | 0.560 |
Why?
|
Biopsy, Needle | 7 | 2014 | 1630 | 0.550 |
Why?
|
Catheterization | 9 | 2015 | 1426 | 0.550 |
Why?
|
Omentum | 1 | 2017 | 169 | 0.550 |
Why?
|
Bile Ducts | 4 | 2021 | 282 | 0.540 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2021 | 9273 | 0.540 |
Why?
|
Organs at Risk | 1 | 2018 | 358 | 0.540 |
Why?
|
Femoral Nerve | 1 | 2016 | 42 | 0.530 |
Why?
|
Adenoma, Pleomorphic | 1 | 2016 | 75 | 0.520 |
Why?
|
Intestinal Perforation | 1 | 2017 | 249 | 0.510 |
Why?
|
Respiratory Insufficiency | 1 | 2024 | 1230 | 0.510 |
Why?
|
Urinary Fistula | 1 | 2015 | 43 | 0.510 |
Why?
|
Liver | 7 | 2021 | 7502 | 0.490 |
Why?
|
Dissection | 1 | 2017 | 297 | 0.490 |
Why?
|
Nephrectomy | 3 | 2021 | 1016 | 0.490 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2016 | 102 | 0.480 |
Why?
|
Gallbladder | 1 | 2016 | 305 | 0.480 |
Why?
|
Parotid Neoplasms | 1 | 2016 | 157 | 0.480 |
Why?
|
Hepatic Artery | 1 | 2016 | 230 | 0.480 |
Why?
|
Duodenum | 1 | 2017 | 485 | 0.470 |
Why?
|
Bile Duct Neoplasms | 3 | 2015 | 602 | 0.470 |
Why?
|
Abscess | 4 | 2011 | 605 | 0.460 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2016 | 187 | 0.460 |
Why?
|
Adrenal Gland Neoplasms | 5 | 2019 | 733 | 0.460 |
Why?
|
Male | 85 | 2024 | 358747 | 0.450 |
Why?
|
Hematuria | 1 | 2015 | 233 | 0.450 |
Why?
|
Humans | 128 | 2024 | 758406 | 0.450 |
Why?
|
Fiducial Markers | 1 | 2015 | 132 | 0.450 |
Why?
|
Glomerular Filtration Rate | 2 | 2019 | 2154 | 0.440 |
Why?
|
Abdominal Neoplasms | 2 | 2013 | 286 | 0.440 |
Why?
|
Radiopharmaceuticals | 4 | 2018 | 2634 | 0.440 |
Why?
|
Kidney | 8 | 2021 | 7016 | 0.440 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2024 | 1463 | 0.440 |
Why?
|
Appendectomy | 1 | 2017 | 431 | 0.440 |
Why?
|
Biopsy | 11 | 2021 | 6768 | 0.430 |
Why?
|
Hematologic Diseases | 2 | 2017 | 496 | 0.430 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2016 | 328 | 0.430 |
Why?
|
Female | 84 | 2024 | 390323 | 0.430 |
Why?
|
Hepatectomy | 4 | 2021 | 559 | 0.430 |
Why?
|
Lymphoproliferative Disorders | 1 | 2017 | 533 | 0.430 |
Why?
|
Arteriovenous Fistula | 1 | 2016 | 313 | 0.410 |
Why?
|
Pelvic Neoplasms | 1 | 2014 | 248 | 0.400 |
Why?
|
Celiac Plexus | 1 | 2011 | 28 | 0.390 |
Why?
|
Neuroendocrine Tumors | 2 | 2016 | 650 | 0.390 |
Why?
|
Lithium Compounds | 1 | 2013 | 225 | 0.390 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2012 | 101 | 0.390 |
Why?
|
Time Factors | 16 | 2021 | 39872 | 0.390 |
Why?
|
Autonomic Nerve Block | 1 | 2011 | 80 | 0.370 |
Why?
|
Magnetic Resonance Imaging | 18 | 2021 | 36284 | 0.360 |
Why?
|
Suction | 2 | 2011 | 262 | 0.360 |
Why?
|
Pain, Intractable | 1 | 2011 | 132 | 0.360 |
Why?
|
Mediastinal Diseases | 1 | 2011 | 91 | 0.360 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 590 | 0.350 |
Why?
|
Appendicitis | 1 | 2017 | 674 | 0.350 |
Why?
|
Pulmonary Veins | 1 | 2016 | 745 | 0.340 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1277 | 0.340 |
Why?
|
Radiation Dosage | 7 | 2020 | 1956 | 0.340 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2015 | 800 | 0.330 |
Why?
|
Liver Transplantation | 1 | 2021 | 2325 | 0.330 |
Why?
|
Antimanic Agents | 1 | 2013 | 520 | 0.330 |
Why?
|
Predictive Value of Tests | 9 | 2021 | 15225 | 0.330 |
Why?
|
Ascites | 1 | 2011 | 338 | 0.330 |
Why?
|
Urinary Bladder | 2 | 2015 | 1166 | 0.330 |
Why?
|
Lymphoma | 1 | 2018 | 1896 | 0.330 |
Why?
|
Adrenal Glands | 2 | 2003 | 554 | 0.330 |
Why?
|
Feasibility Studies | 6 | 2020 | 5199 | 0.320 |
Why?
|
Abdomen | 1 | 2015 | 1129 | 0.320 |
Why?
|
Diagnostic Imaging | 6 | 2013 | 3526 | 0.320 |
Why?
|
Melanoma | 2 | 2018 | 5691 | 0.310 |
Why?
|
Contrast Media | 12 | 2017 | 5298 | 0.310 |
Why?
|
Hemorrhage | 2 | 2018 | 3400 | 0.310 |
Why?
|
Urinary Bladder Neoplasms | 4 | 2018 | 2276 | 0.300 |
Why?
|
Enteral Nutrition | 1 | 2013 | 785 | 0.280 |
Why?
|
Adult | 46 | 2024 | 219935 | 0.280 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2010 | 329 | 0.280 |
Why?
|
Pancreatectomy | 1 | 2011 | 810 | 0.270 |
Why?
|
Neoplasm Staging | 8 | 2021 | 11152 | 0.270 |
Why?
|
Body Mass Index | 2 | 2021 | 12876 | 0.270 |
Why?
|
Tumor Burden | 5 | 2019 | 1893 | 0.250 |
Why?
|
Gastrointestinal Diseases | 1 | 2013 | 1185 | 0.250 |
Why?
|
Abdominal Pain | 1 | 2011 | 1063 | 0.240 |
Why?
|
Endometrial Neoplasms | 2 | 2014 | 1357 | 0.240 |
Why?
|
Carcinoma | 1 | 2016 | 2330 | 0.240 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2239 | 0.230 |
Why?
|
Urinary Catheterization | 3 | 2011 | 198 | 0.230 |
Why?
|
Collagen | 1 | 2012 | 2635 | 0.220 |
Why?
|
Immunotherapy | 1 | 2018 | 4641 | 0.210 |
Why?
|
Postoperative Complications | 7 | 2018 | 15637 | 0.200 |
Why?
|
Radiation Protection | 2 | 2016 | 425 | 0.200 |
Why?
|
Colorectal Neoplasms | 2 | 2020 | 6852 | 0.200 |
Why?
|
Sensitivity and Specificity | 10 | 2017 | 14641 | 0.200 |
Why?
|
Risk Factors | 11 | 2024 | 73809 | 0.200 |
Why?
|
Diagnosis, Differential | 8 | 2021 | 12951 | 0.190 |
Why?
|
Ethiodized Oil | 1 | 2021 | 25 | 0.190 |
Why?
|
Kidney Failure, Chronic | 1 | 2013 | 2457 | 0.180 |
Why?
|
Catheters | 1 | 2023 | 421 | 0.180 |
Why?
|
Neoplasm Seeding | 2 | 2013 | 84 | 0.180 |
Why?
|
Bile | 1 | 2021 | 297 | 0.170 |
Why?
|
Disease-Free Survival | 3 | 2020 | 6821 | 0.170 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2020 | 172 | 0.170 |
Why?
|
Injections | 2 | 2015 | 830 | 0.170 |
Why?
|
Hypertrophy | 1 | 2021 | 555 | 0.160 |
Why?
|
Urography | 3 | 2015 | 312 | 0.160 |
Why?
|
Radio Waves | 2 | 2017 | 250 | 0.160 |
Why?
|
Follow-Up Studies | 14 | 2021 | 39059 | 0.160 |
Why?
|
Device Removal | 1 | 2023 | 633 | 0.160 |
Why?
|
Deglutition Disorders | 1 | 2024 | 625 | 0.150 |
Why?
|
Portal Vein | 1 | 2021 | 429 | 0.150 |
Why?
|
Obesity | 1 | 2020 | 12870 | 0.150 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 211 | 0.150 |
Why?
|
Bone Marrow Transplantation | 3 | 2015 | 2693 | 0.140 |
Why?
|
Esophagus | 1 | 2022 | 1023 | 0.140 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2016 | 2004 | 0.140 |
Why?
|
Liver Abscess | 2 | 2009 | 81 | 0.130 |
Why?
|
Water | 2 | 2015 | 1402 | 0.130 |
Why?
|
Ovarian Neoplasms | 3 | 2010 | 4876 | 0.130 |
Why?
|
Ureter | 1 | 2018 | 375 | 0.130 |
Why?
|
Cohort Studies | 6 | 2021 | 41256 | 0.130 |
Why?
|
Kidney Function Tests | 1 | 2018 | 677 | 0.130 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2014 | 296 | 0.130 |
Why?
|
Adenoma, Oxyphilic | 1 | 2017 | 148 | 0.130 |
Why?
|
Body Temperature | 1 | 2018 | 777 | 0.130 |
Why?
|
Antigens, Heterophile | 1 | 2015 | 70 | 0.130 |
Why?
|
Cholecystectomy | 1 | 2017 | 406 | 0.120 |
Why?
|
Ethanol | 2 | 2011 | 1323 | 0.120 |
Why?
|
Glucose | 3 | 2015 | 4336 | 0.120 |
Why?
|
Young Adult | 8 | 2019 | 58808 | 0.120 |
Why?
|
Critical Pathways | 1 | 2018 | 473 | 0.120 |
Why?
|
Debridement | 1 | 2017 | 492 | 0.120 |
Why?
|
Catecholamines | 1 | 2015 | 385 | 0.120 |
Why?
|
Retreatment | 1 | 2016 | 596 | 0.120 |
Why?
|
Positron-Emission Tomography | 4 | 2016 | 6457 | 0.120 |
Why?
|
Iatrogenic Disease | 1 | 2017 | 538 | 0.120 |
Why?
|
Creatinine | 2 | 2018 | 1892 | 0.120 |
Why?
|
Radiographic Image Enhancement | 3 | 2016 | 875 | 0.120 |
Why?
|
Iodine | 1 | 2016 | 286 | 0.120 |
Why?
|
Inguinal Canal | 1 | 2014 | 71 | 0.110 |
Why?
|
Neoplasms | 5 | 2023 | 22032 | 0.110 |
Why?
|
Combined Modality Therapy | 5 | 2021 | 8530 | 0.110 |
Why?
|
Papio | 1 | 2015 | 661 | 0.110 |
Why?
|
Adrenalectomy | 1 | 2015 | 348 | 0.110 |
Why?
|
Tomography, Emission-Computed | 2 | 2010 | 1121 | 0.110 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 1 | 2016 | 200 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6493 | 0.110 |
Why?
|
Biliary Tract Neoplasms | 1 | 2015 | 184 | 0.110 |
Why?
|
Brachytherapy | 1 | 2021 | 1236 | 0.110 |
Why?
|
Ureteral Obstruction | 3 | 2008 | 292 | 0.110 |
Why?
|
Hospitals, Urban | 1 | 2015 | 500 | 0.110 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 1986 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2019 | 5249 | 0.100 |
Why?
|
Flank Pain | 1 | 2012 | 43 | 0.100 |
Why?
|
Risk Assessment | 5 | 2021 | 23884 | 0.100 |
Why?
|
Biopsy, Fine-Needle | 1 | 2017 | 1110 | 0.100 |
Why?
|
Physical Therapy Modalities | 1 | 2016 | 536 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2016 | 567 | 0.100 |
Why?
|
Urinary Calculi | 1 | 2012 | 91 | 0.100 |
Why?
|
Endoscopy | 1 | 2002 | 1834 | 0.100 |
Why?
|
Tissue Plasminogen Activator | 2 | 2008 | 1156 | 0.100 |
Why?
|
Neoplasm, Residual | 3 | 2013 | 1007 | 0.100 |
Why?
|
Testicular Diseases | 1 | 2012 | 73 | 0.100 |
Why?
|
Swine | 3 | 2023 | 5892 | 0.100 |
Why?
|
Phenol | 1 | 2011 | 44 | 0.100 |
Why?
|
Reoperation | 4 | 2018 | 4282 | 0.100 |
Why?
|
Fluoroscopy | 4 | 2008 | 944 | 0.100 |
Why?
|
Salvage Therapy | 1 | 2018 | 1268 | 0.100 |
Why?
|
Protein Kinase Inhibitors | 2 | 2019 | 5629 | 0.090 |
Why?
|
Vulvar Neoplasms | 1 | 2014 | 263 | 0.090 |
Why?
|
Observer Variation | 2 | 2014 | 2600 | 0.090 |
Why?
|
Immunity, Humoral | 1 | 2015 | 604 | 0.090 |
Why?
|
Patient Care Planning | 1 | 2016 | 907 | 0.090 |
Why?
|
Phantoms, Imaging | 2 | 2017 | 2509 | 0.090 |
Why?
|
Urinary Bladder Neck Obstruction | 1 | 2011 | 81 | 0.090 |
Why?
|
Cryotherapy | 1 | 2011 | 161 | 0.090 |
Why?
|
Disease Progression | 4 | 2020 | 13468 | 0.090 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2011 | 127 | 0.090 |
Why?
|
Hospitals, General | 1 | 2015 | 795 | 0.090 |
Why?
|
Exons | 1 | 2016 | 2387 | 0.090 |
Why?
|
Hypnotics and Sedatives | 1 | 2018 | 1176 | 0.090 |
Why?
|
Adenoma | 1 | 2000 | 2148 | 0.090 |
Why?
|
Prostatic Diseases | 1 | 2010 | 57 | 0.090 |
Why?
|
Algorithms | 3 | 2018 | 13961 | 0.080 |
Why?
|
Cholangiography | 1 | 2009 | 181 | 0.080 |
Why?
|
Pelvic Pain | 1 | 2012 | 298 | 0.080 |
Why?
|
Urinary Bladder, Neurogenic | 1 | 2011 | 174 | 0.080 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12096 | 0.080 |
Why?
|
Pancreatic Neoplasms | 2 | 2020 | 5349 | 0.080 |
Why?
|
Urination Disorders | 1 | 2010 | 240 | 0.080 |
Why?
|
Prognosis | 6 | 2021 | 29557 | 0.080 |
Why?
|
Survival Analysis | 2 | 2019 | 10112 | 0.080 |
Why?
|
Cholangitis | 1 | 2009 | 113 | 0.080 |
Why?
|
Catheters, Indwelling | 1 | 2011 | 428 | 0.080 |
Why?
|
Reproducibility of Results | 6 | 2021 | 20055 | 0.080 |
Why?
|
Odds Ratio | 2 | 2018 | 9650 | 0.080 |
Why?
|
Fluorocarbons | 1 | 1994 | 489 | 0.080 |
Why?
|
Linear Models | 1 | 2018 | 5862 | 0.070 |
Why?
|
Urinary Diversion | 1 | 2008 | 135 | 0.070 |
Why?
|
Adolescent | 10 | 2018 | 87892 | 0.070 |
Why?
|
Radiosurgery | 1 | 2017 | 1342 | 0.070 |
Why?
|
Logistic Models | 3 | 2018 | 13276 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2014 | 815 | 0.070 |
Why?
|
Lymph Node Excision | 1 | 2014 | 1303 | 0.070 |
Why?
|
Transplantation, Heterologous | 1 | 2015 | 2378 | 0.070 |
Why?
|
Boston | 4 | 2015 | 9304 | 0.070 |
Why?
|
Respiration | 1 | 2013 | 1654 | 0.070 |
Why?
|
Body Fluids | 1 | 2008 | 319 | 0.070 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2016 | 1214 | 0.070 |
Why?
|
Nephritis | 1 | 2007 | 147 | 0.070 |
Why?
|
Hemangioma | 1 | 2011 | 727 | 0.070 |
Why?
|
Nanoparticles | 1 | 2018 | 1940 | 0.070 |
Why?
|
Liver Diseases | 1 | 2014 | 1296 | 0.070 |
Why?
|
Artifacts | 1 | 2014 | 1897 | 0.060 |
Why?
|
Pyrazoles | 1 | 2016 | 1988 | 0.060 |
Why?
|
Ultrasonography | 3 | 2013 | 5952 | 0.060 |
Why?
|
Recovery of Function | 1 | 2016 | 2970 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3570 | 0.060 |
Why?
|
Musculoskeletal Diseases | 1 | 2011 | 595 | 0.060 |
Why?
|
Cold Temperature | 1 | 2008 | 780 | 0.060 |
Why?
|
Pelvic Infection | 1 | 2004 | 12 | 0.060 |
Why?
|
Pyridines | 1 | 2016 | 2859 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2016 | 13245 | 0.060 |
Why?
|
Histocompatibility Antigens | 1 | 2005 | 467 | 0.060 |
Why?
|
Kidney Diseases, Cystic | 1 | 2005 | 183 | 0.060 |
Why?
|
Fibrosis | 1 | 2010 | 2038 | 0.050 |
Why?
|
Survival Rate | 5 | 2018 | 12721 | 0.050 |
Why?
|
Vagina | 1 | 2008 | 838 | 0.050 |
Why?
|
Electric Power Supplies | 1 | 2023 | 98 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2010 | 3527 | 0.050 |
Why?
|
Antibiotic Prophylaxis | 1 | 2008 | 642 | 0.050 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2009 | 1214 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2018 | 1436 | 0.050 |
Why?
|
Biliary Tract Surgical Procedures | 1 | 2002 | 45 | 0.050 |
Why?
|
Patient Selection | 2 | 2012 | 4244 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7403 | 0.050 |
Why?
|
Transplantation Chimera | 1 | 2005 | 595 | 0.050 |
Why?
|
Major Histocompatibility Complex | 1 | 2005 | 928 | 0.050 |
Why?
|
Electronics | 1 | 2023 | 315 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2015 | 8945 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4738 | 0.050 |
Why?
|
Immune Tolerance | 2 | 2015 | 2297 | 0.050 |
Why?
|
Vinblastine | 2 | 2000 | 487 | 0.050 |
Why?
|
Adrenal Gland Diseases | 1 | 2003 | 141 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2014 | 2016 | 0.050 |
Why?
|
Teleradiology | 1 | 2001 | 53 | 0.050 |
Why?
|
Radiology | 2 | 2011 | 2102 | 0.050 |
Why?
|
Hydronephrosis | 2 | 2008 | 271 | 0.040 |
Why?
|
Practice Guidelines as Topic | 3 | 2012 | 7378 | 0.040 |
Why?
|
Genital Diseases, Female | 1 | 2001 | 191 | 0.040 |
Why?
|
Medical Oncology | 1 | 2011 | 2312 | 0.040 |
Why?
|
Digestive System | 1 | 2000 | 244 | 0.040 |
Why?
|
Gastric Bypass | 1 | 2008 | 817 | 0.040 |
Why?
|
Urinary Incontinence | 1 | 2003 | 495 | 0.040 |
Why?
|
Escherichia coli Infections | 1 | 2003 | 523 | 0.040 |
Why?
|
Radiography | 4 | 2012 | 6954 | 0.040 |
Why?
|
Surgical Wound Infection | 1 | 2008 | 1526 | 0.040 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1998 | 41 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2014 | 4023 | 0.040 |
Why?
|
Chronic Disease | 1 | 2013 | 9267 | 0.040 |
Why?
|
Fibrinolytic Agents | 1 | 2008 | 2071 | 0.040 |
Why?
|
Splanchnic Circulation | 1 | 1998 | 110 | 0.040 |
Why?
|
Splenic Artery | 1 | 1998 | 57 | 0.040 |
Why?
|
Radioisotope Teletherapy | 1 | 1997 | 15 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5246 | 0.040 |
Why?
|
Graft Survival | 2 | 2005 | 3794 | 0.040 |
Why?
|
Cisplatin | 2 | 2000 | 1645 | 0.040 |
Why?
|
Child | 5 | 2018 | 79818 | 0.030 |
Why?
|
Colonic Polyps | 1 | 2001 | 551 | 0.030 |
Why?
|
Methotrexate | 2 | 2000 | 1719 | 0.030 |
Why?
|
Neoplasm Invasiveness | 3 | 2018 | 3617 | 0.030 |
Why?
|
Cystectomy | 2 | 2018 | 697 | 0.030 |
Why?
|
Bipolar Disorder | 1 | 2013 | 5079 | 0.030 |
Why?
|
Electromagnetic Phenomena | 1 | 2017 | 161 | 0.030 |
Why?
|
Cell Lineage | 1 | 2005 | 2533 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2019 | 529 | 0.030 |
Why?
|
Antibodies, Heterophile | 1 | 2015 | 128 | 0.030 |
Why?
|
Radionuclide Imaging | 2 | 2013 | 1975 | 0.030 |
Why?
|
Aortography | 1 | 2016 | 420 | 0.030 |
Why?
|
Hydrocarbons, Brominated | 1 | 1994 | 29 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 2018 | 416 | 0.030 |
Why?
|
Equipment Design | 2 | 2013 | 3507 | 0.030 |
Why?
|
Pancreas | 1 | 2020 | 1676 | 0.030 |
Why?
|
Prospective Studies | 6 | 2018 | 54137 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 2008 | 2882 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3069 | 0.030 |
Why?
|
Emulsions | 1 | 1994 | 152 | 0.030 |
Why?
|
History, 18th Century | 1 | 2014 | 207 | 0.030 |
Why?
|
Utilization Review | 1 | 2015 | 382 | 0.030 |
Why?
|
Indocyanine Green | 1 | 2014 | 236 | 0.030 |
Why?
|
Fluorine Radioisotopes | 1 | 2015 | 413 | 0.030 |
Why?
|
Animals | 9 | 2023 | 167768 | 0.030 |
Why?
|
History, 20th Century | 2 | 2014 | 2772 | 0.030 |
Why?
|
Graft vs Host Disease | 1 | 2005 | 3024 | 0.030 |
Why?
|
Coloring Agents | 1 | 2014 | 560 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3099 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3563 | 0.020 |
Why?
|
Pilot Projects | 2 | 2019 | 8553 | 0.020 |
Why?
|
Scrotum | 1 | 2012 | 116 | 0.020 |
Why?
|
History, 19th Century | 1 | 2014 | 720 | 0.020 |
Why?
|
Treatment Failure | 1 | 2017 | 2640 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1594 | 0.020 |
Why?
|
Rabbits | 2 | 1995 | 4772 | 0.020 |
Why?
|
Patient Positioning | 1 | 2013 | 327 | 0.020 |
Why?
|
Prostatic Neoplasms | 2 | 2011 | 11336 | 0.020 |
Why?
|
Needles | 1 | 2013 | 451 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2005 | 4217 | 0.020 |
Why?
|
Urethra | 2 | 2003 | 406 | 0.020 |
Why?
|
User-Computer Interface | 1 | 2016 | 1397 | 0.020 |
Why?
|
Sex Distribution | 1 | 2015 | 2284 | 0.020 |
Why?
|
Aorta | 1 | 2017 | 2037 | 0.020 |
Why?
|
Societies, Medical | 1 | 2021 | 3891 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3299 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2882 | 0.020 |
Why?
|
Mutation | 3 | 2019 | 29915 | 0.020 |
Why?
|
Cell Death | 1 | 2014 | 1668 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2014 | 748 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2000 | 11709 | 0.020 |
Why?
|
Chest Tubes | 1 | 2008 | 152 | 0.020 |
Why?
|
England | 1 | 2008 | 524 | 0.020 |
Why?
|
Pyrimidines | 1 | 2019 | 3006 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2013 | 2896 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4113 | 0.020 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 1659 | 0.020 |
Why?
|
Preoperative Care | 1 | 2015 | 2249 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2015 | 1470 | 0.020 |
Why?
|
Pain | 1 | 2020 | 5065 | 0.020 |
Why?
|
Colon | 2 | 2005 | 1787 | 0.020 |
Why?
|
Kidney Tubules, Collecting | 1 | 2005 | 163 | 0.020 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2005 | 516 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12440 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2010 | 827 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10748 | 0.010 |
Why?
|
Viscera | 1 | 2004 | 138 | 0.010 |
Why?
|
Sus scrofa | 1 | 2005 | 428 | 0.010 |
Why?
|
Perfusion | 1 | 2008 | 1374 | 0.010 |
Why?
|
Pregnancy | 3 | 2015 | 29742 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2000 | 6313 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 2005 | 602 | 0.010 |
Why?
|
Swine, Miniature | 1 | 2005 | 959 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2015 | 2496 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 12945 | 0.010 |
Why?
|
Analysis of Variance | 2 | 2005 | 6234 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16886 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3339 | 0.010 |
Why?
|
Models, Structural | 1 | 2002 | 341 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3425 | 0.010 |
Why?
|
Isoantibodies | 1 | 2005 | 661 | 0.010 |
Why?
|
Hysterosalpingography | 1 | 2000 | 26 | 0.010 |
Why?
|
Uterus | 1 | 2005 | 651 | 0.010 |
Why?
|
Necrosis | 1 | 2005 | 1604 | 0.010 |
Why?
|
Phlebography | 1 | 2002 | 325 | 0.010 |
Why?
|
Pain Measurement | 1 | 2011 | 3527 | 0.010 |
Why?
|
Barium Sulfate | 1 | 2000 | 180 | 0.010 |
Why?
|
Enema | 1 | 2000 | 141 | 0.010 |
Why?
|
Transplantation Tolerance | 1 | 2005 | 605 | 0.010 |
Why?
|
Infant | 2 | 2015 | 36055 | 0.010 |
Why?
|
Fetal Diseases | 1 | 2005 | 911 | 0.010 |
Why?
|
Syndrome | 1 | 2005 | 3262 | 0.010 |
Why?
|
Child, Preschool | 2 | 2015 | 42062 | 0.010 |
Why?
|
Models, Animal | 1 | 2005 | 2112 | 0.010 |
Why?
|
Gingival Hemorrhage | 1 | 1998 | 49 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 2005 | 1264 | 0.010 |
Why?
|
Polyvinyls | 1 | 1998 | 154 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2008 | 2768 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2000 | 1570 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2000 | 638 | 0.010 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2000 | 623 | 0.010 |
Why?
|
Splenectomy | 1 | 1998 | 391 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2005 | 4809 | 0.010 |
Why?
|
Gestational Age | 1 | 2005 | 3565 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23342 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1997 | 1628 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2015 | 26183 | 0.010 |
Why?
|
Renal Circulation | 1 | 1995 | 291 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2005 | 5864 | 0.010 |
Why?
|
Kidney Pelvis | 1 | 1995 | 188 | 0.010 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 1995 | 231 | 0.010 |
Why?
|
Blood Loss, Surgical | 1 | 1998 | 653 | 0.010 |
Why?
|
Renal Artery | 1 | 1995 | 351 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 1997 | 924 | 0.010 |
Why?
|
United States | 2 | 2011 | 72136 | 0.010 |
Why?
|
Angiography | 1 | 1998 | 1599 | 0.010 |
Why?
|
Anticoagulants | 1 | 2008 | 4777 | 0.010 |
Why?
|
Vascular Resistance | 1 | 1995 | 930 | 0.010 |
Why?
|
Pressure | 1 | 1995 | 1155 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2008 | 14490 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1997 | 1791 | 0.010 |
Why?
|
Recurrence | 1 | 2004 | 8426 | 0.010 |
Why?
|
Remission Induction | 1 | 1997 | 2388 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10171 | 0.000 |
Why?
|
Incidence | 1 | 2005 | 21272 | 0.000 |
Why?
|
Blood Pressure | 1 | 1998 | 8451 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2000 | 13591 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1995 | 18119 | 0.000 |
Why?
|